Generics - Generics, Politics

Filter

Current filters:

GenericsPolitics

Popular Filters

1 to 25 of 60 results

India revisits plans for free generic medicines, drug price fixing

India revisits plans for free generic medicines, drug price fixing

11-12-2014

Government hospitals in India that lack medicines, are overcrowded and understaffed, may soon be a thing…

FinancialGenericsHealthcareIndiaPharmaceuticalPoliticsPricing

GPhA slams mischaracterized facts about generic drug pricing

GPhA slams mischaracterized facts about generic drug pricing

24-11-2014

Commenting on recent evaluations of generic drug prices, Ralph Neas, president and chief executive of…

GenericsLegalPoliticsPricingUSA

India takes action on spurious and sub-standard drugs

India takes action on spurious and sub-standard drugs

10-11-2014

An American pharmacist and an Indian pharmacologist charged with smuggling four million fake pharmaceuticals…

GenericsIndiaMarkets & MarketingPharmaceuticalPoliticsRegulation

US Congressmen investigate “staggering price increases” for generic drugs

US Congressmen investigate “staggering price increases” for generic drugs

10-10-2014

Letters have been sent to 14 drug manufacturers, including several major Indian firms, requesting information…

GenericsPoliticsPricingUSA

Update: Negotiations on EU-Canada Free Trade Agreement concluded

Update: Negotiations on EU-Canada Free Trade Agreement concluded

29-09-2014

Canadian trade group Research-Based Pharmaceutical Companies (Rx&D) expressed its support to the government…

CanadaEuropeGenericsMarkets & MarketingPatentsPoliticsRegulation

Indian industry decries smear campaign against its pharma exporters

Indian industry decries smear campaign against its pharma exporters

26-09-2014

The India Brand Equity Foundation (IBEF), on behalf of the government of India, has taken strong objection…

Antibiotics and Infectious diseasesGenericsIndiaMarkets & MarketingPoliticsProductionUSA

Bill to increase competition for generic drugs introduced in USA

Bill to increase competition for generic drugs introduced in USA

19-09-2014

US Representatives Steve Stivers (Republican, Ohio) Peter Welch (Democrat, Vermont) on Thursday joined…

GenericsLegalPoliticsRegulationUSA

US Senators call for immediate release of guidance on biosimilar drugs

US Senators call for immediate release of guidance on biosimilar drugs

06-08-2014

US Senators Lamar Alexander (Republican, Tennessee) and Orrin Hatch (Rep, Utah) have led colleagues in…

BiosimilarsGenericsPoliticsRegulationUS Food and Drug AdministrationUSA

South Africa’s NAPM calls for elimination of VAT on medicines

22-07-2014

South African trade group the National Association of Pharmaceutical Manufacturers (NAPM) has proposed…

FinancialGenericsNational Association of Pharmaceutical ManufacturersPoliticsPricingSouth Africa

South Africa trade group intensifies efforts on generics access

03-07-2014

South Africa’s National Association of Pharmaceutical Manufacturer’s has appointed its new Executive…

GenericsHealthcarePoliticsPricingSouth Africa

Congressional hearing in Brazil will discuss the efficacy of generic medicines

26-05-2014

The Brazilian Commission for Consumer Protection will soon hold a hearing to discuss the effectiveness…

BrazilGenericsPoliticsRegulation

Australian Audit Commission’s “nuclear option to attack the PBS is madness”

Australian Audit Commission’s “nuclear option to attack the PBS is madness”

05-05-2014

The Australian National Commission of Audit’s complete dismantling and destruction of the Pharmaceutical…

AustraliaFinancialGenericsHealthcarePolitics

Indian govt plans to support a competitive pharma sector, especially for SMEs

Indian govt plans to support a competitive pharma sector, especially for SMEs

14-04-2014

In a bid to strengthen the existing infrastructure facilities and to enable the Indian pharmaceutical…

Asia-PacificGenericsIndiaMarkets & MarketingPoliticsProduction

Despite focus on generics, South Korean pharma market to reach $24.3 billion by 2020

Despite focus on generics, South Korean pharma market to reach $24.3 billion by 2020

10-04-2014

As a result of a high level of access to health care insurance and reimbursement, coupled with increasing…

Asia-PacificGenericsMarkets & MarketingPolitics

EGA president seeks partnership with Italian government on generics and biosimilars

09-04-2014

The president of the European Generic Medicines Association (EGA), Nick Haggar, attended the Stati Generali…

BiosimilarsEuropeGenericsItalyMarkets & MarketingPolitics

US/EU generic industries call for thoughtful changes to speed medicines to patients

US/EU generic industries call for thoughtful changes to speed medicines to patients

08-04-2014

In a joint letter sent to the European Commission and the Office of the US Trade Representative, the…

EuropeGenericsPoliticsRegulationUSA

European generic drug makers sets out priorities for EU Trade Policy

European generic drug makers sets out priorities for EU Trade Policy

02-04-2014

European Generic Medicines Association (EGA) revealed this morning that its president, Nick Haggar, has…

EuropeGenericsPoliticsRegulationRest of the World

GMiA calls on Australian government to think before irreversible damage occurs to the generic medicines industry

GMiA calls on Australian government to think before irreversible damage occurs to the generic medicines industry

13-03-2014

At the Annual Professional Pharmacy (APP) conference in Australia today, Mark Crotty, chairman of the…

Asia-PacificAustraliaGenericsHealthcarePolitics

PhRMA slams US President’s claims that Budget invests in innovation

06-03-2014

Pharmaceutical Research and Manufacturers of America (PhRMA) president and chief executive John Castellani…

GenericsNorth AmericaPatentsPharmaceuticalPoliticsResearchUSA

US Congressmen express concerns on FDA’s proposed change to generic drug labeling policy

US Congressmen express concerns on FDA’s proposed change to generic drug labeling policy

30-01-2014

US Senator Lamar Alexander (Republican, Tennessee), the senior Republican on the Senate Health Committee,…

GenericsNorth AmericaPoliticsRegulationUSA

Mixed views on Grattan Institute report on drug price cuts impact in Australia

Mixed views on Grattan Institute report on drug price cuts impact in Australia

03-12-2013

The Grattan Institute has published an updated report on Australia's drug pricing, which has been applauded…

Asia-PacificAustraliaGenericsPoliticsPricing

No changes in Australian domestic IP warranted, say generic drugmakers

No changes in Australian domestic IP warranted, say generic drugmakers

26-11-2013

Members of the generic drugs industry are calling on the Australian government to support efforts to…

Asia-PacificGenericsNorth AmericaPatentsPolitics

MSF warns of US/Indian tension over generic policy discussion

MSF warns of US/Indian tension over generic policy discussion

25-09-2013

Humanitarian group Médecins Sans Frontières has warned that India is facing political pressure from…

Anti-viralsAsia-PacificBayerGenericsGleevecHealthcareNexavarNorth AmericaNovartisPolitics

Australia needs policies that increase generic medicine use

24-09-2013

Australia’s Generic Medicines Industry Association strongly refutes claims by the Consumer Health Forum…

Asia-PacificGenericsMarkets & MarketingPolitics

1 to 25 of 60 results

Back to top